Research map: ASO Practice Guidelines Series: Resectable Colorectal Cancer

Back to the article

Papers in this map

  1. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries · Hyuna Sung · 2021 · 114646 citations · Cited by this paper
  2. ASO Author Reflections: Preserving the Liver, Not Just Minimizing the Incision · Maria Christodoulou · 2026 · Related
  3. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries · Freddie Bray · 2024 · 26051 citations · Cited by this paper
  4. ICG-only Sentinel Lymph Node Biopsy in Breast Cancer: A Prospective UK Cohort Demonstrating Consistent Detection Across Patient and Tumour Characteristics—A Follow-on to the INFLUENCE Trial · 2026 · Related
  5. Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2016 for the treatment of colorectal cancer · Japanese Society for Cancer of the Colon and Rectum · 2017 · 2496 citations · Cited by this paper
  6. ASO Visual Abstract: Resection of Primary Lung Tumors in Patients with Stage IV EGFR-Mutant Lung Adenocarcinoma before Progression under First-Line TKI Treatment and Its Impact on Prognosis · 2026 · Related
  7. Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancer · Yojiro Hashiguchi · 2019 · 2012 citations · Cited by this paper
  8. ASO Visual Abstract: Surgical Management of Young Women with High-Risk Breast Cancer Receiving Neoadjuvant Systemic Therapy in the I-SPY2 Trial · 2026 · Related
  9. Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data · Monique Maas · 2010 · 1983 citations · Cited by this paper
  10. ASO Visual Abstract: Risk of pN2/3 Understaging in Sentinel Node-Positive ER+/HER2− Breast Cancer: A Composite Clinicopathologic Score for Safe RxPONDER and MonarchE Application · 2026 · Related
  11. Mesorectal excision for rectal cancer · John K. MacFarlane · 1993 · 1771 citations · Cited by this paper
  12. Surgical Management of Young Women with High-Risk Breast Cancer Receiving Neoadjuvant Systemic Therapy on the I-SPY2 Trial · 2026 · Related
  13. Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial · Renu R. Bahadoer · 2020 · 1722 citations · Cited by this paper
  14. Who is at Risk of Residual Tumor and Pathologic Upstaging at a Second TURBT in Non–Muscle-Invasive Bladder Cancer? · 2026 · Related
  15. Standardized surgery for colonic cancer: complete mesocolic excision and central ligation – technical notes and outcome · Werner Hohenberger · 2008 · 1668 citations · Cited by this paper
  16. ASO Visual Abstract: Timing of Surgical Axillary Staging and Impact on Technical Success of Immediate Lymphatic Reconstruction Following Axillary Lymph Node Dissection · 2026 · Related
  17. PD-1 Blockade in Mismatch Repair–Deficient, Locally Advanced Rectal Cancer · Andrea Cercek · 2022 · 1659 citations · Cited by this paper
  18. ASO Visual Abstract: Prognostic Relevance of Surgical Margins According to KRAS and BRAF Status in Colorectal Liver Metastases—BRAF-KRAS LiverMet Collaborative Group · 2026 · Related
  19. Neoadjuvant immunotherapy leads to pathological responses in MMR-proficient and MMR-deficient early-stage colon cancers · Myriam Chalabi · 2020 · 1439 citations · Cited by this paper
  20. Clinical and Functional Impact of CHMP3 in Pancreatic Ductal Adenocarcinoma · 2026 · Related
  21. Localised colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up · Guillem Argilés · 2020 · 1404 citations · Cited by this paper
  22. Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER-PRODIGE 23): a multicentre, randomised, open-label, phase 3 trial · Thierry Conroy · 2021 · 1366 citations · Cited by this paper
  23. Duration of Adjuvant Chemotherapy for Stage III Colon Cancer · Axel F. Grothey · 2018 · 1156 citations · Cited by this paper
  24. Circulating Tumor DNA Analysis Guiding Adjuvant Therapy in Stage II Colon Cancer · Jeanne Tie · 2022 · 1082 citations · Cited by this paper
  25. Randomized Trial of Short-Course Radiotherapy Versus Long-Course Chemoradiation Comparing Rates of Local Recurrence in Patients With T3 Rectal Cancer: Trans-Tasman Radiation Oncology Group Trial 01.04 · Samuel Y. Ngan · 2012 · 933 citations · Cited by this paper
  26. Rectal Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology · Al B. Benson · 2022 · 864 citations · Cited by this paper
  27. Circumferential Margin Involvement Is Still an Important Predictor of Local Recurrence in Rectal Carcinoma · Irıs D. Nagtegaal · 2002 · 749 citations · Cited by this paper
  28. Preoperative Treatment of Locally Advanced Rectal Cancer · Deborah Schrag · 2023 · 493 citations · Cited by this paper
  29. Disease-free survival after complete mesocolic excision compared with conventional colon cancer surgery: a retrospective, population-based study · Claus Anders Bertelsen · 2014 · 489 citations · Cited by this paper
  30. Preoperative Chemotherapy for Operable Colon Cancer: Mature Results of an International Randomized Controlled Trial · Dion G. Morton · 2023 · 480 citations · Cited by this paper
  31. Neoadjuvant Immunotherapy in Locally Advanced Mismatch Repair–Deficient Colon Cancer · Myriam Chalabi · 2024 · 471 citations · Cited by this paper
  32. Organ preservation for clinical T2N0 distal rectal cancer using neoadjuvant chemoradiotherapy and local excision (ACOSOG Z6041): results of an open-label, single-arm, multi-institutional, phase 2 trial · Julio García‐Aguilar · 2015 · 439 citations · Cited by this paper
  33. Neoadjuvant Modified FOLFOX6 With or Without Radiation Versus Fluorouracil Plus Radiation for Locally Advanced Rectal Cancer: Final Results of the Chinese FOWARC Trial · Yanhong Deng · 2019 · 409 citations · Cited by this paper
  34. Locoregional Failure During and After Short-course Radiotherapy Followed by Chemotherapy and Surgery Compared With Long-course Chemoradiotherapy and Surgery · Esmée A. Dijkstra · 2023 · 389 citations · Cited by this paper
  35. Colon Cancer, Version 3.2024, NCCN Clinical Practice Guidelines in Oncology · Al B. Benson · 2024 · 369 citations · Cited by this paper
  36. Organ preservation with chemoradiotherapy plus local excision for rectal cancer: 5-year results of the GRECCAR 2 randomised trial · Éric Rullier · 2020 · 271 citations · Cited by this paper
  37. Total Mesorectal Excision – The New Golden Standard of Surgery for Rectal Cancer · Warren E. Enker · 1997 · 252 citations · Cited by this paper
  38. Total neoadjuvant therapy with mFOLFIRINOX versus preoperative chemoradiotherapy in patients with locally advanced rectal cancer: long-term results of the UNICANCER-PRODIGE 23 trial · Thierry Conroy · 2024 · 229 citations · Cited by this paper
  39. Localised rectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up · Ralf‐Dieter Hofheinz · 2025 · 192 citations · Cited by this paper

Source: OpenAlex (CC0)